Skip to main content
ArticleOPEN ACCESS

Correction to: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis (Journal of Translational Medicine, (2018), 16, 1, (57), 10.1186/s12967-018-1433-7)

Journal of Translational Medicine
DOI: 10.1186/s12967-021-02869-4
1Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Cite

CITATION STYLE

APA

Riordan, N. H., Morales, I., Fernández, G., Allen, N., Fearnot, N. E., Leckrone, M. E., … Rodriguez, J. P. (2021, December 1). Correction to: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis (Journal of Translational Medicine, (2018), 16, 1, (57), 10.1186/s12967-018-1433-7). Journal of Translational Medicine. BioMed Central Ltd. https://doi.org/10.1186/s12967-021-02869-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free